He succeeds Interim CEO Paul LaViolette, who will remain chairman of the board.
Mr. Bruneau has more than 20 years of experience in the medical device industry, including executive roles at Zimmer Biomet, Biomet Microfixation and Medtronic, according to his LinkedIn profile.
Since December 2017, Mr. Bruneau spearheaded the spine, robotic and craniomaxillofacial/thoracic surgery businesses at Zimmer Biomet. As group president, he managed a department with $750 million in annual revenues, as well as 1,200 team members and business partners.
His core achievements at Zimmer Biomet include leading robotic technology through development and commercialization, creating speedy growth innovations in spine surgery and earning FDA-approvals in several markets.
More articles on devices:
Medical freeze placed on NuVasive spinal rods in UK, Ireland
Michigan Head and Spine Institute surgeons take 45% pay cut during COVID-19
Nonsurgical procedures, mediocre care & COVID-19: 3 spine surgeons on the biggest threat to their practice
